•
Dec 31, 2021

2Seventy Bio Q4 2021 Earnings Report

Total Revenue
$16M
Previous year: $9.91M
+61.9%
EPS
-$2.55
Previous year: -$5.14
-50.4%
Gross Profit
$15.6M
Previous year: $8.41M
+85.9%
Cash and Equivalents
$130M
Free Cash Flow
-$58.4M
Previous year: -$60.8M
-4.0%
Total Assets
$760M
Previous year: $313M
+143.0%

2Seventy Bio

2Seventy Bio